Group 1 - The total scale of ETFs has reached 4.16 trillion yuan as of June 9, 2023, with an increase of nearly 440 billion yuan this year and a total of 2.74 trillion shares, indicating widespread recognition and application of ETFs as financial instruments [1] - There are 14 ETFs that have added over 10 billion yuan in scale this year, with the highest single product adding over 30 billion yuan, primarily in stock and commodity funds, particularly in gold-themed and broad-based products [1] - The performance of innovative drug companies has improved, leading to a general increase in the net value growth rate of related thematic funds, with many funds showing growth rates above 40% [2][3] Group 2 - The international trade situation presents significant uncertainties, which may increase the demand for gold assets, especially as the dollar is at its lowest level in three years, potentially supporting gold prices [2] - A total of 136 new ETFs have been issued this year, bringing the total to 1,191, with the materials sector seeing the largest increase in shares, and the China Innovation Drug Industry Index being the most tracked theme [2] - The innovative drug sector has experienced a strong market performance due to multiple favorable factors, including improved sentiment and significant capital inflows, marking a transition into a harvest period for innovative drug companies [3]
年内规模新增超百亿元ETF达14只 黄金主题和宽基居多
Zheng Quan Ri Bao·2025-06-09 16:17